Article thumbnail

Deficiency of mast cells in coronary artery endarterectomy of male patients with type 2 diabetes

By Aleš Pleskovič, Olga Vraspir-Porenta, Ruda Zorc-Pleskovič, Danijel Petrovič, Metka Zorc and Aleksandra Milutinović
Topics: Original Investigation
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3112392
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1999). A: Immunological modulation of human cardiac mast cells. Neurochem Res
  2. (1999). Atherosclerosis–an inflammatory disease.
  3. (2008). C-reactive protein, cytokines and inflammation in cardiovascular diseases. Bratisl Lek Listy
  4. (2000). Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation
  5. (1997). Coronary risk factors and plaque morphology in men with coronary disease who died suddenly.
  6. (2004). DE: Critical role of mast cells in inflammatory diseases and the effect of acute stress.
  7. (2002). Endogenous heparin - a protective marker in patient with myocardial infartion. Coron Artery Dis
  8. (1995). Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation
  9. (2005). Inflammation, atherosclerosis, and coronary artery disease.
  10. (2008). Kalogeromitros D: Impact of stress and mast cells on brain metastases.
  11. (2004). Kovanen PT: Mast cells in neovascularized human coronary plaques store and secrete basic fibroblast growth factor, a potent angiogenic mediator. Arterioscler Thromb Vasc Biol
  12. (2006). Mast cell biology in evolution.
  13. (2004). Mechanisms of leukocyte recruitment to atherosclerotic lesions: future prospects. Curr Opin Lipidol
  14. (1999). Morphometrical and stereological analysis of myocardial mast cells in myocarditis and dilated cardiomyopathy. Folia Biol (Praha)
  15. (2007). Peterlin B: Association of vascular endothelial growth factor gene polymorphism with myocardial infarction in patients with type 2 diabetes. Cardiology
  16. (2009). Petrovic D: Polymorphisms in the promoter region of the basic fibroblast growth factor gene are not associated with myocardial infarction in a Slovene population with type 2 diabetes.
  17. (2007). RL: Mast cell-restricted tryptases: structure and function in inflammation and pathogen defense.
  18. (2008). Saraga-Babic M: Developmental patterns of caspase-3, bax and bcl-2 proteins expression in the human spinal ganglia. J Mol Histol
  19. (2008). SJ: New developments in mast cell biology. Nat Immunol
  20. (2002). SM: Elevated levels of acutephase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes
  21. (2010). St John AL: Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol
  22. (1979). Stereological methods. Practical Methods for Biological Morphometry.
  23. (1997). The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care
  24. (2006). Tse HF: Mast cell contributes to cardiomyocyte apoptosis after coronary microembolization. J Histochem Cytochem
  25. (2007). Zorc-Pleskovic R: The interleukin-1 receptor antagonist gene and the inhibitor of kappa B-like protein gene polymorphisms are not associated with myocardial infarction in Slovene population with type 2 diabetes. Coll Antropol